載入...

Biosimilar Insulins: How Similar is Similar?

Biosimilar insulins (BIs) are viewed as commercially attractive products by a number of companies. In order to obtain approval in the European Union or the United States, where there is not a single BI currently on the market, a manufacturer needs to demonstrate that a given BI has a safety and effi...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Heinemann, Lutz, Hompesch, Marcus
格式: Artigo
語言:Inglês
出版: Diabetes Technology Society 2011
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192641/
https://ncbi.nlm.nih.gov/pubmed/21722590
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!